Price T Rowe Associates Inc. MD Has $227.88 Million Holdings in Cardinal Health, Inc. $CAH

Key Points

• Price T Rowe Associates Inc. MD has increased its stake in Cardinal Health, Inc. by 3.3%, now owning approximately $227.88 million worth of shares.
• Recent insider trades reveal significant share sales by CEO Stephen M. Mason and another insider, indicating a combined total of over $40 million in shares sold last quarter.
• Cardinal Health plans to pay a quarterly dividend of $0.5107 per share on October 15th, which equates to an annualized yield of 1.4%.

Price T Rowe Associates Inc. MD raised its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 3.3% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,654,036 shares of the company's stock after buying an additional 52,714 shares during the quarter. Price T Rowe Associates Inc. MD owned 0.69% of Cardinal Health worth $227,877,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the stock. Pinnacle Bancorp Inc. increased its stake in Cardinal Health by 11.2% in the 1st quarter. Pinnacle Bancorp Inc. now owns 767 shares of the company's stock valued at $106,000 after buying an additional 77 shares during the period. Applied Finance Capital Management LLC increased its stake in Cardinal Health by 1.4% in the 1st quarter. Applied Finance Capital Management LLC now owns 6,049 shares of the company's stock valued at $833,000 after buying an additional 85 shares during the period. CSS LLC IL increased its stake in Cardinal Health by 0.8% in the 4th quarter. CSS LLC IL now owns 11,190 shares of the company's stock valued at $1,323,000 after buying an additional 90 shares during the period. Perigon Wealth Management LLC increased its stake in Cardinal Health by 4.2% in the 1st quarter. Perigon Wealth Management LLC now owns 2,242 shares of the company's stock valued at $309,000 after buying an additional 90 shares during the period. Finally, Smith Shellnut Wilson LLC ADV increased its stake in Cardinal Health by 2.1% in the 1st quarter. Smith Shellnut Wilson LLC ADV now owns 4,399 shares of the company's stock valued at $606,000 after buying an additional 91 shares during the period. Institutional investors and hedge funds own 87.17% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the stock. Citigroup reiterated a "neutral" rating and issued a $170.00 price objective (up previously from $157.00) on shares of Cardinal Health in a research note on Friday, June 13th. UBS Group reissued a "buy" rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Robert W. Baird boosted their target price on shares of Cardinal Health from $197.00 to $203.00 and gave the stock an "outperform" rating in a research report on Wednesday, August 13th. Leerink Partners decreased their target price on shares of Cardinal Health from $188.00 to $186.00 and set an "outperform" rating for the company in a research report on Tuesday, August 12th. Finally, Wall Street Zen downgraded shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 2nd. Twelve equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $163.20.

Insider Buying and Selling at Cardinal Health

In related news, CEO Stephen M. Mason sold 41,575 shares of the company's stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the sale, the chief executive officer directly owned 26,085 shares of the company's stock, valued at approximately $3,881,969.70. This represents a 61.45% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Ola M. Snow sold 28,151 shares of the company's stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the sale, the insider directly owned 15,431 shares of the company's stock, valued at approximately $2,298,293.14. This represents a 64.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 271,676 shares of company stock worth $40,489,525 in the last quarter. 0.09% of the stock is owned by corporate insiders.

Cardinal Health Trading Down 2.3%

NYSE CAH opened at $148.0430 on Friday. The company has a fifty day simple moving average of $159.02 and a 200 day simple moving average of $145.45. The company has a market cap of $35.35 billion, a P/E ratio of 22.95, a P/E/G ratio of 1.25 and a beta of 0.67. Cardinal Health, Inc. has a 1 year low of $106.54 and a 1 year high of $168.44.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.03 by $0.05. The business had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. Cardinal Health's quarterly revenue was up .5% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Equities research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be issued a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a dividend yield of 1.4%. The ex-dividend date of this dividend is Wednesday, October 1st. Cardinal Health's dividend payout ratio is currently 31.63%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.